SECONDARY PROPHYLAXIS OF VENOUS THROMBOEMBOLISM (VTE) WITH LOW DOSE APIXABAN OR RIVAROXABAN: RESULTS FROM A PATIENT POPULATION WITH MORE THAN 2 YEARS OF MEDIAN FOLLOW-UP. Mediterr J Hematol Infect Dis 2024, 16 (1), e2024020. https://doi.org/10.4084/MJHID.2024.020.